Dr. A. Pramod Kumar

• Pharmacovigilance
• Materiovigilance
• Adverse Event Following Immunization

• “LEE Foundation Award’, in attending ‘Asian Association of Schools of Pharmacy’ conference conducted by National University of Singapore, Singapore, 14th to 16th Nov 2013.
• Best Technical Associate award by National Coordination Centre, ‘Pharmacovigilance Programme of India’ from Drugs Controller General of India (DCGI), 2015.
• Best poster award in the ASICON, 9th National Conference on AIDS society of India’, Mumbai, 7th to 9th October 2016.
• Best poster award in 3rd International Conference on Pharmacovigilance and Clinical Trails, 27th — 29th October 2014, Hyderabad (OMICS Group).
• Best poster award in the KSPOR, P4 5th National Conference on Patient safety and Pharmacoeconomics’ held at Krupanidhi College, Bangalore, 21st & 22nd Aug. 2015.
• Awarded with ‘APACC Conference Participation Grant’ for attending 2nd International Asia Pacific AIDS and Co-infections Conference at Hong Kong, 1st June – 3rd June 2017.
• Presented with Pillar of strength award by Bioclinica Pvt. Ltd. (contract research organisation) in the year 2019.

National Journal Papers

• Adusumilli, P.K. and Adepu, R., 2014. Drug related problems: an over view of various classification systems. Asian J Pharm Clin Res, 7(4), pp.7 – 10.
• Thota, P., Thota, A., Medhi, B., Sidhu, S., Kumar, P., Selvan, V.K. and Singh, G.N., 2018. Drug safety alerts of pharmacovigilance programme of India: A scope for targeted spontaneous reporting in India. Perspectives in clinical research, 9(1), p.51.
• Adepu, R. and Adusumilli, P.K., 2016. Assessment of Drug related problems in patients with chronic diseases through Health Status Survey in a South Indian Rural Community setting. Indian Journal of Pharmaceutical Sciences, 78(4), pp.537 – 541.
• Agrawal, V., Shrivastava, T.P., Adusumilli, P.K., Vivekanandan, K., Thota, P. and Bhushan, S., 2019. Pivotal role of Pharmacovigilance Programme of India in containment of antimicrobial resistance in India. Perspectives in clinical research, 10(3), p.140.
• Kumar, A.P., Prasad, S.R., Parthasarathi, G. and Krishna, U., 2018. Assessment of adverse drug reactions to antiretroviral agents among HIV patients. Journal of Applied Pharmaceutical Science, 8(2), pp.079 – 082.
• Kumar, V., Kalaiselvan, V., Kumar, A.P., Saurabh, A., Thota, P., Sidhu, S. and Medhi, B., 2018. Cefixime-associated acute generalized exanthematous pustulosis: Rare cases in India. Indian Journal of Pharmacology, 50(4), p.204.
• Kumar, P., Kaur, I., Kalaiselvan, V. and Singh, A., 2017. Safety monitoring of local anaesthetic drugs from the perspective of Pharmacovigilance Programme of India. Indian Journal of Anaesthesia, 61(7), p.534.
• Kumar, A.P., Sarathi, G.P., Sudheer, A.P., Mothi, S.N., Swamy, V.H. and Rao, Srirama, 2017. Incidence and risk factors of renal impairment in HIV‑1 infected patients receiving tenofovir based antiretroviral therapy in a South Indian hospital. Int J Pharm Pharm Sci, 9, pp.152 – 5.
• Kumar, A.P., Bhoopathi, D., Sunkara, Haripriya, and Chalasani, S.H., 2020. An Overview of Various Scales Used In Causality Assessment Of Adverse Drug Reactions. Int J Pharm Pharm Sci.
• Lokesh, R.V., Adusumilli Pramod, K., Shashi, B., Kalaiselvan, V. and Nath, S.G., 2019. Integration of Pharmacy Education and Pharmacovigilance: Scope and Challenges in India. Ind J Pharma Edu Res, 53(2), pp.202 – 7.
• Dharini, B., Reddy, N., Deepalakshmi, M. and Kumar, P., 2018. Knowledge, Attitude, and Practice toward Pharmacovigilance and adverse drug reaction reporting among nursing staff and students. Asian Journal of Pharmaceutical and Clinical Research, pp.62 – 67.
• Rahul K. P., Pramod Adusumilli, K., Raghava K. M., Samaksha P. B., Manohar G. A., Krishna U. Safety and Effectiveness of Hydroxychloroquine in the treatment of Type‑2 Diabetes Mellitus: A Systematic Review and Meta-analysis of Randomized Controlled Trials. Journal of Young Pharmacist, 14(4), pp.402 – 7.
• Clinical Outcomes of Use of Hydroxychloroquine in Paradoxical Tuberculosus-Immune Reconstitution Inflammatory Syndrome in HIV-Infected Patients. Asian Journal of Pharmaceutical and Clinical Research 11(2), pp. 439 – 41.

• Life Member, AIDS Society of India

• 02
• Chemotherapy Nursing Device for Cancer Patients
• Preparation of Formulation and Evaluation of Zolmitriptan immediate release tablets